➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: July 24, 2021

DrugPatentWatch Database Preview

Patent: 10,047,353

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,047,353
Title:Grimonitia-hollisae-derived recombinant collagenase and enzyme agent for cell and tissue dissociation
Abstract: Recombinant collagenases with a stable specific activity and enzyme agents for cell and tissue dissociation such a recombinant are provided. The recombinant collagenase is derived from Grimontia hollisae-derived collagenase is characterized by having, from the N terminus to the C terminus, a collagenase catalytic domain, a linker region sequence, and a prepeptidase C terminal domain, which Grimontia hollisae-derived recombinant collagenase does not comprise at least the prepeptidase C terminal domain. The obtained recombinant collagenase has a high and stable specific activity.
Inventor(s): Teramura; Naoko (Tokyo, JP), Iijima; Katsumasa (Tokyo, JP), Hayashida; Osamu (Tokyo, JP), Tanaka; Keisuke (Tokyo, JP), Hattori; Shunji (Tokyo, JP), Okitsu; Teru (Tokyo, JP), Takeuchi; Shoji (Tokyo, JP)
Assignee: Nippi, Incorporated (Tokyo, JP) The University of Tokyo (Tokyo, JP)
Application Number:15/123,986
Patent Claims:see list of patent claims

Details for Patent 10,047,353

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04 ⤷  Free Forever Trial Nippi, Incorporated (Tokyo, JP) The University of Tokyo (Tokyo, JP) 2034-03-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,047,353

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2015133636 ⤷  Free Forever Trial
United States of America 2017218352 ⤷  Free Forever Trial
South Korea 20160131037 ⤷  Free Forever Trial
Japan 6661072 ⤷  Free Forever Trial
Japan WO2015133636 ⤷  Free Forever Trial
European Patent Office 3115455 ⤷  Free Forever Trial
China 106164269 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.